◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2508

Saint Bella Group Limited (2508) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-10

Saint Bella Group Limited (2508) operates in the Medical Care Facilities industry and is headquartered in Hangzhou, China with about 1,642 employees. Its market capitalization is roughly CNY 2 billion. In the fiscal year ended 2025-12-31, 2508 reported CNY 1.0B in revenue and CNY 408M in net income.

Saint Bella Group Limited engages in the operation of postpartum care centers, home care services, and food products business in China, Hong Kong, Singapore, the United States, and internationally.

Interactive charts & full statements →

2508 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 1.0BCNY 799MCNY 560MCNY 472M
Gross ProfitCNY 376MCNY 270MCNY 205MCNY 141M
Operating Income (EBIT)CNY 91M(CNY 54M)CNY 8M(CNY 45M)
Net IncomeCNY 408M(CNY 547M)(CNY 239M)(CNY 408M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2508 Free Cash Flow History

2508 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 1.5BCNY 622MCNY 469MCNY 405M
Total LiabilitiesCNY 551MCNY 2.1BCNY 1.4BCNY 1.1B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2508 viewer.

Other Companies in Medical Care Facilities

← 2507All “0-9” companies2509 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.